FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Foat Timothy G
2. Date of Event Requiring Statement (MM/DD/YYYY)
10/11/2019 

3. Issuer Name and Ticker or Trading Symbol

Bio-Matrix Scientific Group, Inc. [BMSN]
(Last)        (First)        (Middle)

1204 TANGERINE ST
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                          _____ 10% Owner
___X___ Officer (give title below)        _____ Other (specify below)
Chief Executive Officer /
(Street)

EL CAJON, CA 92021-5011      

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed(MM/DD/YYYY)
 

6. Individual or Joint/Group Filing(Check Applicable Line)

_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 12500000 I Trustee Sherman Family Trust 
Common Stock 792500 I Trustee Bio-Technology Partners Business Trust 
Common Stock 3020143 I President Dunhill Ross Partners, Inc (1)
Common Stock 437143 I President BioScientific Consultants 
Common Stock 3757 I President Sunset Cliffs Compliance 
Preferred Stock 1068 I President BioScientific Consultants 
Preferred Stock 2300 I Trustee Bio-Technology Partners Business Trust 
Preferred Stock 1187 I President Dunhill Ross Partners (1)
Preferred Series B Stock 2678 I President BioScientific Consultants 
Preferred Series B Stock 179 I Trustee Bio-Technology Partners Business Trust 
Preferred Series B Stock 2041 I President Dunhill Ross Partners (1)
Preferred Series B Stock 75 I President Sunset Cliffs Compliance 

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares

Explanation of Responses:
(1) Formerly Venture Bridge Advisors, Inc

Remarks:
On May 23,2013 Venture Bridge Advisors, Inc (a Nevada Corporation) changes its name to Dunhill Ross Partners, Inc (A Nevada Corporation). The stock in Venture Bridge Advisors name predates this name change and has not been reissued.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Foat Timothy G
1204 TANGERINE ST
EL CAJON, CA 92021-5011


Chief Executive Officer

Signatures
Timothy G Foat12/23/2019
**Signature of Reporting PersonDate

Bio Matrix Scientific (PK) (USOTC:BMSN)
Historical Stock Chart
From Apr 2020 to May 2020 Click Here for more Bio Matrix Scientific (PK) Charts.
Bio Matrix Scientific (PK) (USOTC:BMSN)
Historical Stock Chart
From May 2019 to May 2020 Click Here for more Bio Matrix Scientific (PK) Charts.